For example, CRISPR/Cas9 made it possible to establish that LRP1 is one of the main proteins responsible for the capture and distribution of the misfolded tau protein within the brain [60], and to consider neural LRP1 as a potential target for the pathogenetic therapies for Alzheimer’s disease. The gene discussed is LRP1; the disease is early-onset autosomal dominant Alzheimer disease.